We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients

This study is currently recruiting participants.
Verified October 2016 by José A. Mira Escarti, Valme University Hospital
Sponsor:
ClinicalTrials.gov Identifier:
NCT02057003
First Posted: February 6, 2014
Last Update Posted: October 17, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborators:
Hospital Universitario Reina Sofia
Hospital Universitario Virgen de la Victoria
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Hospital Regional de Malaga
Hospital Torrecárdenas
Complejo Hospitalario Universitario de Huelva
Hospital Universitario Puerta del Mar
Hospital Universitario Virgen Macarena
Hospital La Línea
Complejo Hospitalario de Jaén
Hospital Universitario Puerto Real
Hospital Universitario de Canarias
Hospital Poniente
Hospital Universitario Central de Asturias
Hospital Álvaro Cunqueiro
Hospital Universitario Virgen de la Arrixaca
Hospital Universitario de Gran Canaria
Information provided by (Responsible Party):
José A. Mira Escarti, Valme University Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2020
  Estimated Primary Completion Date: December 2020 (Final data collection date for primary outcome measure)

To Top